Literature DB >> 27739691

Fragment-to-Lead Medicinal Chemistry Publications in 2015.

Christopher N Johnson1, Daniel A Erlanson2, Christopher W Murray1, David C Rees1.   

Abstract

Fragment-based drug discovery (FBDD) is now well-established as a technology for generating new chemical leads and drugs. This Miniperspective provides a tabulated overview of the fragment-to-lead literature published in the year 2015, together with a commentary on trends observed across the FBDD field during this time. It is hoped that this tabulated summary will provide a useful point of reference for both FBDD practitioners and the wider medicinal chemistry community.

Mesh:

Year:  2016        PMID: 27739691     DOI: 10.1021/acs.jmedchem.6b01123

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Discovery of CDK8/CycC Ligands with a New Virtual Screening Tool.

Authors:  Wei Chen; Xiaodong Ren; Chia-En A Chang
Journal:  ChemMedChem       Date:  2018-12-10       Impact factor: 3.466

2.  Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A 2A adenosine receptor binding site.

Authors:  Pierre Matricon; Anirudh Ranganathan; Eugene Warnick; Zhan-Guo Gao; Axel Rudling; Catia Lambertucci; Gabriella Marucci; Aitakin Ezzati; Mariama Jaiteh; Diego Dal Ben; Kenneth A Jacobson; Jens Carlsson
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

Review 3.  Fragment-to-Lead Medicinal Chemistry Publications in 2020.

Authors:  Iwan J P de Esch; Daniel A Erlanson; Wolfgang Jahnke; Christopher N Johnson; Louise Walsh
Journal:  J Med Chem       Date:  2021-12-20       Impact factor: 7.446

4.  The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors-A Spin-Off Discovery from Fragment Screening.

Authors:  Sarah L Mueller; Panagiotis K Chrysanthopoulos; Maria A Halili; Caryn Hepburn; Tom Nebl; Claudiu T Supuran; Alessio Nocentini; Thomas S Peat; Sally-Ann Poulsen
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

Review 5.  Current perspectives in fragment-based lead discovery (FBLD).

Authors:  Bas Lamoree; Roderick E Hubbard
Journal:  Essays Biochem       Date:  2017-11-08       Impact factor: 8.000

Review 6.  Fragment-based drug discovery: opportunities for organic synthesis.

Authors:  Jeffrey D St Denis; Richard J Hall; Christopher W Murray; Tom D Heightman; David C Rees
Journal:  RSC Med Chem       Date:  2020-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.